CTEV Latest News | Stock Alarm Pro

CTEVCTEV

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Latest News

businesswire.com

Claritev Corporation Announces Fourth Quarter 2025 Earnings Conference Call

MCLEAN, Va--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its fourth quarter and fiscal year 2025 financial results after market close on Monday, February 23, 2026, and hold a conference call at 4:30 pm Eastern Time. To join the conference call, please pre-register using the link below. Participant.

businesswire.com

Claritev and Kinetiq Health Enter Into Strategic Agreement to Strengthen Cost Management and Advance Claims Surveillance and Diagnostic Certainty

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent, and fair for all, today announced a strategic relationship with Kinetiq Health, a healthcare risk management organization specializing in claims surveillance, diagnostic certainty, and cost intervention strategies. Rising medical and pharmacy costs are often driven by a small number of complex, high-cost.

seekingalpha.com

Claritev Corporation (CTEV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

businesswire.com

Claritev Corporation to Present at J.P. Morgan Healthcare Conference

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced its participation in the 44th Annual J.P. Morgan Healthcare Conference. Management will be presenting on Thursday, January 15, 2026 at 7:30 a.m. PT. A live webcast and audio archive of the presentation will be available through the investor relations section of Claritev's.

seekingalpha.com

Claritev Corporation (CTEV) Presents at Bank of America Leveraged Finance Conference Transcript

businesswire.com

Claritev Corporation Announces Participation at Upcoming Conferences

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Announces Participation at Upcoming Conferences.

businesswire.com

Claritev Corporation Announces Pricing of Offering of Class A Common Stock by Selling Stockholders

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the pricing of an underwritten public offering (the “Offering”) of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the “Class A common stock”), by certain affiliates of Hellman & Friedman (collectively, the “Selling Stockholders”) at a price.

businesswire.com

Claritev Corporation Announces Public Offering of Class A Common Stock by Selling Stockholders

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the commencement of an underwritten public offering (the “Offering”) of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the “Class A common stock”), by certain affiliates of Hellman & Friedman (collectively, the “Selling Stockholders”). The.

seekingalpha.com

Claritev Corporation (CTEV) Q3 2025 Earnings Call Transcript

Claritev Corporation ( CTEV ) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants Todd Friedman - Vice President of Investor Relations Travis Dalton - CEO, President & Chairman Doug Garis - Executive VP & CFO Conference Call Participants Joshua Raskin - Nephron Research LLC Daniel Grosslight - Citigroup Inc. Exchange Research Jessica Tassan - Piper Sandler & Co., Research Division Presentation Operator Hello, everyone, and thank you for joining us today for the Claritev Corporation Third Quarter Earnings Call. My name is Sami, and I'll be coordinating your call today.

zacks.com

Claritev Corporation (CTEV) Reports Q3 Loss, Tops Revenue Estimates

Claritev Corporation (CTEV) came out with a quarterly loss of $4.07 per share versus the Zacks Consensus Estimate of a loss of $3.12. This compares to a loss of $1.85 per share a year ago.

businesswire.com

Claritev Corporation Reports Third Quarter 2025 Results

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Reports Third Quarter 2025 Results.

businesswire.com

Claritev Invests in Klaim, Inc. to Accelerate Provider Payment Solutions Across the U.S. and MENA Region

MCCLEAN, Va. & RIYADH, Saudi Arabia--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a global leader in healthcare analytics and claims analysis, today announced a strategic investment in Klaim, Inc., an AI-driven healthcare payment-acceleration solutions provider. The investment will help fund the launch of a co-branded Payment Acceleration Service integrated within Claritev's extensive provider network, helping healthcare organizations gain faster and more pr.

businesswire.com

Claritev Corporation Announces Third Quarter 2025 Earnings Conference Call

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Announces Third Quarter 2025 Earnings Call.

businesswire.com

Claritev and iO Health Forge Strategic Relationship to Bring AI-Powered Revenue Cycle Management Optimization to the MENA Region

MCLEAN, Va. & DUBAI, United Arab Emirates--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, and iO Health-FZE, an innovator in AI-driven healthcare technology, today announced a strategic agreement aimed at delivering Optima AI across the Middle East and North Africa (MENA). Through this agreement, Claritev has secured exclusive rights to license,.

businesswire.com

Claritev Expands Golf Sponsorships, Re-Signs Neal Shipley and Adds Bud Cauley, Ryan Fox and Darren Clarke

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it has renewed its sponsorship agreement with professional golfer Neal Shipley and signed new sponsorship agreements with Bud Cauley, Ryan Fox and Darren Clarke. These endorsements reflect Claritev's commitment to supporting athletes who exemplify resilience, determinatio.

businesswire.com

Claritev Earns 2025 Great Place To Work® Certification™ and Makes Fortune's Best Workplaces in Health Care™ List Again

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, is proud to announce it has been Certified™ by Great Place To Work® for the fourth consecutive year. The prestigious award is based entirely on what current employees say about their experience working at Claritev. This year, 76% of employees said it's a great place to work – 19 points h.

seekingalpha.com

Claritev Corporation (CTEV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Claritev Corporation (NYSE:CTEV ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 4:05 PM EDT Company Participants Travis Dalton - CEO, President & Chairman Doug Garis - Executive VP & CFO Conference Call Participants Dan Bray - Morgan Stanley Presentation Dan Bray Managing Director Good afternoon, everyone. I'm Dan Bray, Managing Director in the Morgan Stanley Healthcare Group.

zacks.com

Claritev Corporation (CTEV) Q2 Earnings and Revenues Surpass Estimates

Claritev Corporation (CTEV) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of a loss of $2.69 per share. This compares to a loss of $1.2 per share a year ago.

businesswire.com

Claritev Corporation Reports Second Quarter 2025 Results

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Reports Second Quarter 2025 Results.

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance